Takeda Pharmaceutical (TAK) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock TAK Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Takeda Pharmaceutical (TSE:4502): Is the Market Missing Its True Valuation Potential?October 10 at 2:19 AM | finance.yahoo.comCrohn’s Disease Market Report 2034: Epidemiology Insights, Pipeline Developments, and Key Regulatory Approvals (FDA, EMA, PMDA) | Published by DelveInsight | Featuring ...October 8, 2025 | theglobeandmail.comTakeda to test wind-powered cargo vesselOctober 8, 2025 | finance.yahoo.comMassachusetts’ largest biopharma employer to lay off 137 people in CambridgeOctober 6, 2025 | msn.comHow Investors May Respond To Takeda Pharmaceutical (TSE:4502) Exiting Cell Therapy to Refocus R&D PrioritiesOctober 3, 2025 | finance.yahoo.comBristol Myers, Takeda, Astex to contribute data for AI tool, Reuters saysOctober 1, 2025 | msn.comUNOPS and Takeda partner to tackle Bangladesh's medical waste crisisOctober 1, 2025 | msn.comTrump’s latest 100 percent tariff on pharmaceuticals: What we knowSeptember 26, 2025 | msn.comShares of Asian drugmakers drop after Trump imposes tariffsSeptember 26, 2025 | msn.comShares of Asian drugmakers drop after Trump threatens tariffsSeptember 26, 2025 | finance.yahoo.comNew report uncovers disturbing truth about medical waste: 'Complex, inconsistent and fragmented'September 19, 2025 | yahoo.comHow RFK Jr. Could Eliminate Vaccines Without Banning ThemSeptember 18, 2025 | msn.comIn ‘biotech winter,’ Boston startups, jobs, and science are being swept awaySeptember 15, 2025 | bostonglobe.comBTakeda Pharmaceutical (TSE:4502) Prepares For Leadership Transition With New ExecutivesSeptember 12, 2025 | finance.yahoo.comTakeda recruits Lilly executive to run US operations out of CambridgeSeptember 12, 2025 | bostonglobe.comBTakeda (TSE:4502) Valuation in Focus After Narcolepsy Trial Success and VONVENDI FDA ExpansionSeptember 8, 2025 | finance.yahoo.comNovavax COVID-19 Vaccine Approved In Japan, Triggers Milestone Payment From Partner TakedaSeptember 4, 2025 | msn.comNovartis returns to alpha-synuclein with $2.2bn Arrowhead dealSeptember 3, 2025 | msn.comLyophilized Injectable Drugs Market Report 2025: Emerging Trends, Opportunities, Challenges and Leading Player Growth StrategiesSeptember 1, 2025 | finance.yahoo.comGlobal Pharmaceuticals Market to Register Immense Growth at a CAGR of ~7% by 2032 | DelveInsightAugust 28, 2025 | finance.yahoo.comTakeda's Fruzaqla Publicly Reimbursed In Quebec For Treatment Of Metastatic Colorectal CancerAugust 28, 2025 | finanznachrichten.deBinge Eating Disorders Global Market Research Report 2025-2035 Featuring Eli Lilly, Amneal, Takeda, Tryp Therapeutics, Tonix, Sumitomo, VIVUS, Novartis, and PfizeAugust 27, 2025 | finance.yahoo.comNew study reveals long road to seizure control for people with focal epilepsyAugust 26, 2025 | msn.comTakeda executive hikes up Mount Fuji to promote need for plasma donationsAugust 25, 2025 | bostonglobe.comBMultiple Myeloma Global and Regional Market Analysis and Forecast Report 2025-2035 | Johnson & Johnson, Sanofi, AbbVie, Bristol-Myers Squibb, Takeda, Pfizer Drive Innovation ...August 11, 2025 | finance.yahoo.comTakeda, Cosmo extend partnership on ulcerative colitis treatmentAugust 8, 2025 | msn.comBlackstone Plans to Take Japan’s TechnoPro PrivateAugust 7, 2025 | msn.comNovavax raises annual revenue forecast on vaccine supply partnershipsAugust 6, 2025 | msn.comEDITORIAL – Waiting for a vaccineAugust 4, 2025 | msn.comTrump demands drug companies lower prices before end of SeptemberJuly 31, 2025 | ft.comTakeda Pharmaceutical Co Ltd (TKPHF) Q1 2026 Earnings Call Highlights: Navigating Challenges ...July 31, 2025 | finance.yahoo.comTakeda Pharmaceutical Co Ltd (TAK) Reports Q1 FY2025 Results Amidst Generic Erosion Challenges ...July 30, 2025 | gurufocus.com4TAK : Insights Ahead: Takeda Pharmaceutical's Quarterly EarningsJuly 29, 2025 | benzinga.comPost-Operative Nausea and Vomiting Market Report 2025: Surge in Surgical Procedures Fuels $2.97 Billion Growth in PONV Market by 2029July 25, 2025 | finance.yahoo.comWhat's behind a spike in adverse event reports for Vyvanse, Australia's biggest ADHD drug?July 25, 2025 | msn.comTakeda Pharmaceutical (TAK) Gets GAMMAGARD LIQUID ERC Approved by FDAJuly 15, 2025 | finance.yahoo.comTakeda Stock Gains 3.5% After Positive Phase 3 Results for Narcolepsy DrugJuly 14, 2025 | msn.comTakeda’s oral narcolepsy drug shines in two Phase III trialsJuly 14, 2025 | finance.yahoo.comTakeda Pharmaceutical Co Ltd (TAK) Announces Successful Phase 3 Trials for Oveporexton in ...July 14, 2025 | gurufocus.comAlerts: Takeda Report Highlights Company's Commitment to Cutting-Edge Science, Putting Patients FirstJuly 10, 2025 | finanznachrichten.deDengue vaccine maker explains withdrawal of US, Singapore applicationsJuly 3, 2025 | msn.comDengue vaccine maker awaiting Philippines approvalJuly 3, 2025 | msn.comTakeda Pharmaceutical Co., Ltd. (4502) - Investing.comJuly 1, 2025 | investing.comTakeda Pharmaceutical ADR Earns RS Rating UpgradeJuly 1, 2025 | msn.comFDA approves Takeda’s Gammagard liquid ERC for primary immunodeficiencyJuly 1, 2025 | finance.yahoo.comTakeda Pharmaceuticals Gets FDA Approval for Liquid GammagardJune 30, 2025 | marketwatch.comLupin launches Prucalopride tablets in U.S. marketJune 26, 2025 | msn.comLupin receives USFDA approval for generic Prucalopride tabletsJune 25, 2025 | msn.comLupin gets USFDA nod for new constipation drug, stock gainsJune 25, 2025 | msn.comLabviva Showcases Advanced AI Procurement Tools at the R&D Procurement and Sourcing in Pharma Summit 2025June 19, 2025 | tmcnet.com Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TAK Media Mentions By Week TAK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TAK News Sentiment▼0.101.43▲Average Manufacturing News Sentiment TAK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TAK Articles This Week▼42▲TAK Articles Average Week Get the Latest News and Ratings for TAK and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Takeda Pharmaceutical and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies PBH News Today BHC News Today TLRY News Today CRON News Today ITH News Today AIM News Today GPH News Today APM News Today GXE News Today CRDL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:TAK) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Takeda Pharmaceutical Co Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Takeda Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
